Literature DB >> 27835

Use of antianxiety agents in anxious outpatients.

K Rickels.   

Abstract

The present paper reviews the role of antianxiety agents in the treatment of nonpsychotic anxious patients. Major emphasis is placed on findings from clinical trials conducted by this research group. Consideration is given to the relative efficacy of available antianxiety agents, to patients response in relation to patterns of symptomatology, and to the degree of symptom relief experienced by drug-treated anxious patients. Also discussed are some of the many nonspecific factors that affect improvement with drug treatment in general and with the benzodiazepines in particular. It is concluded that many anxious patients are not currently receiving adequate drug treatment, and may require longer periods of drug therapy or supplemental nondrug intervention.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 27835     DOI: 10.1007/BF00426784

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  54 in total

1.  Psychotropic drugs as therapeutic agents.

Authors:  Gerald L Klerman
Journal:  Stud Hastings Cent       Date:  1974-01

2.  A double-blind study of prazepam versus placebo in single daily doses in the treatment of anxiety.

Authors:  H L Goldberg; R J Finnerty
Journal:  Compr Psychiatry       Date:  1977 Mar-Apr       Impact factor: 3.735

3.  The private practice research group (PPRG): a working model from psychopharmacology for clinical research in family practice.

Authors:  K Rickels; P Hesbacher; E L Fisher; N Norstad
Journal:  J Clin Pharmacol       Date:  1977-10       Impact factor: 3.126

4.  Thiothixene and thioridazine in anxiety.

Authors:  K Rickels; C C Weise; E L Clark; B W Jenkins; C K Rose; H Rosenfeld; P E Gordon
Journal:  Br J Psychiatry       Date:  1974-07       Impact factor: 9.319

5.  Chlordiazepoxide-induced hostility in a small group setting.

Authors:  C Salzman; G E Kochansky; R I Shader; L J Porrino; J S Harmatz; C P Swett
Journal:  Arch Gen Psychiatry       Date:  1974-09

6.  Amitriptyline, diazepam, and phenobarbital sodium in depressed outpatients.

Authors:  K Rickels; H R Chung; H S Feldman; P E Gordon; E A Kelly; C C Weise
Journal:  J Nerv Ment Dis       Date:  1973-12       Impact factor: 2.254

7.  Medication attitudes and drug response.

Authors:  R S Lipman; E H Uhlenhuth; K Rickels; L Covi
Journal:  Dis Nerv Syst       Date:  1969-07

8.  Drug treatment in depression. Antidepressant or tranquilizer?

Authors:  K Rickels; E Raab; R DeSilverio; B Etemad
Journal:  JAMA       Date:  1967-08-28       Impact factor: 56.272

9.  A measure of emotional distress in private gynecologic practice.

Authors:  K Rickels; C R García; E Fisher
Journal:  Obstet Gynecol       Date:  1971-07       Impact factor: 7.661

10.  Comparative evaluation of diazepam (Valium) and phenobarbital.

Authors:  W H Benson
Journal:  J Med Assoc Ga       Date:  1971-08
View more
  15 in total

1.  Benzodiazepine prescriptions and therapist non-compliance.

Authors:  B Geiselmann; M Linden; N Sachs-Ericsson
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

2.  Measuring the Effectiveness of Benzodiazepine Prescriptions Control in Community Setting Using Prescription Drug Monitoring Program (PDMP).

Authors:  Ruchita Agrawal; Shikha Verma; Monica Halappanavar
Journal:  Community Ment Health J       Date:  2020-07-14

3.  Are benzodiazepines overused and abused?

Authors:  K Rickels
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

4.  Pharmacodynamic effects of buspirone and clobazam.

Authors:  C Alford; J Z Bhatti; S Curran; G McKay; I Hindmarch
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

5.  Benzodiazepine anti-anxiety agents: prevalence and correlates of use in a southern community.

Authors:  M Swartz; R Landerman; L K George; M L Melville; D Blazer; K Smith
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

6.  Differential effects of acute and repeated citalopram in mouse models of anxiety and depression.

Authors:  Cedric Mombereau; Tamar L Gur; Jennifer Onksen; Julie A Blendy
Journal:  Int J Neuropsychopharmacol       Date:  2009-12-14       Impact factor: 5.176

7.  Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory function.

Authors:  I Lucki; K Rickels; M A Giesecke; A Geller
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

8.  Rational use of anxiolytic/sedative drugs.

Authors:  M Lader; H Petursson
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

9.  Personal constructs of anxiety under the 1,5-benzodiazepine derivative clobazam related to trait-anxiety levels of the personality.

Authors:  A C Parrott; R Kentridge
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  Adverse performance effects of acute lorazepam administration in elderly long-term users: pharmacokinetic and clinical predictors.

Authors:  Nunzio Pomara; Sang Han Lee; Davide Bruno; Timothy Silber; David J Greenblatt; Eva Petkova; John J Sidtis
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-09-06       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.